NYSE:CAH - Cardinal Health Stock Price, News, & Analysis

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health announced a quarterly dividend on Wednesday, August 8th. Investors of record on Monday, October 1st will be given a dividend of $0.4763 per share on Monday, October 15th. This represents a $1.91 dividend on an annualized basis and a yield of 3.67%. The ex-dividend date of this dividend is Friday, September 28th. This is an increase from Cardinal Health's previous quarterly dividend of $0.48. View Cardinal Health's Dividend History.

Cardinal Health declared that its Board of Directors has initiated a share repurchase plan on Thursday, February 8th 2018, which allows the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company's management believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) released its earnings results on Monday, August, 6th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.08. The firm earned $35.35 billion during the quarter, compared to analyst estimates of $34.38 billion. Cardinal Health had a return on equity of 22.59% and a net margin of 0.19%. Cardinal Health's quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the company earned $1.31 earnings per share. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Monday, November, 5th 2018. View Earnings Estimates for Cardinal Health.

13 Wall Street analysts have issued 12-month price objectives for Cardinal Health's stock. Their forecasts range from $40.00 to $75.00. On average, they expect Cardinal Health's stock price to reach $61.3333 in the next year. This suggests a possible upside of 18.2% from the stock's current price. View Analyst Price Targets for Cardinal Health.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cardinal Health.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), Trxade Group (TRXD), biOasis Technologies (BIOAF) and Medizone International (MZEI).

Media coverage about CAH stock has been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardinal Health earned a coverage optimism score of 0.13 on Accern's scale. They also assigned media stories about the company an impact score of 45.68 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. View Recent Headlines for Cardinal Health.

Cardinal Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.80%), Macquarie Group Ltd. (4.04%), FMR LLC (2.71%), American International Group Inc. (2.44%), Bank of New York Mellon Corp (2.03%) and American Century Companies Inc. (1.44%). Company insiders that own Cardinal Health stock include George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, TCW Group Inc., FMR LLC, Russell Investments Group Ltd., American International Group Inc., Bank of Montreal Can, Wells Fargo & Company MN and Bank of New York Mellon Corp. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was bought by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Millennium Management LLC, American Century Companies Inc., Brandes Investment Partners LP, Dimensional Fund Advisors LP, Los Angeles Capital Management & Equity Research Inc., Thompson Siegel & Walmsley LLC and Morgan Stanley. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $51.90.

Cardinal Health has a market capitalization of $15.04 billion and generates $136.81 billion in revenue each year. The company earns $256 million in net income (profit) each year or $5.00 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]